These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12685798)

  • 1. The market for new diabetes products and the role of third-party payors.
    Reiss JB
    Diabetes Technol Ther; 2002; 4(6):765-9. PubMed ID: 12685798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to get paid for a new diabetes product.
    Reiss JB
    Diabetes Technol Ther; 2002; 4(6):771-4. PubMed ID: 12685799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences across payors in charges for agency-based home health services: evidence from the National Home and Hospice Care Survey.
    Freedman VA; Reschovsky JD
    Health Serv Res; 1997 Oct; 32(4):433-52. PubMed ID: 9327812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare reimbursement for clinical trial services: understanding Medicare coverage in establishing a clinical trial budget.
    Barnes M; Korn J
    J Health Law; 2005; 38(4):609-31. PubMed ID: 16673632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes patient education programs. Quality and reimbursement.
    Wheeler ML; Warren-Boulton E
    Diabetes Care; 1992 Mar; 15 Suppl 1():36-40. PubMed ID: 1559418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engaging Payors and Primary Care Physicians Together in Improving Diabetes Prevention.
    Tseng E; Meza K; Marsteller JA; Clark JM; Maruthur NM; Smith K
    J Gen Intern Med; 2023 Feb; 38(2):309-314. PubMed ID: 36127537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payor issues: barriers to optimal management of patients with primary immunodeficiency.
    Shapiro RS; Boyle M
    J Clin Immunol; 2012 Sep; 32 Suppl 2():S410-4. PubMed ID: 22918575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care financing policy for hospitalized rheumatology patients.
    Munoz E; Goldstein J; Benacquista T; Mulloy K; Wise L
    J Rheumatol; 1989 Jul; 16(7):885-9. PubMed ID: 2504916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standards for the care of diabetes. Origins, uses and implications for third-party payment.
    Clark CM; Kinney ED
    Diabetes Care; 1992 Mar; 15 Suppl 1():10-4. PubMed ID: 1559413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obtaining reimbursement in France and Italy for new diabetes products.
    Schaefer E; Schnell G; Sonsalla J
    J Diabetes Sci Technol; 2015 Jan; 9(1):156-61. PubMed ID: 25550411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategic planning for Medicare coverage and payment of new diabetes technologies.
    Spurgin EA
    Diabetes Technol Ther; 2004 Dec; 6(6):776-81. PubMed ID: 15684629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial billing compliance at academic medical centers.
    Boyd CE; Meade RD
    Acad Med; 2007 Jul; 82(7):646-53. PubMed ID: 17595559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liability of payors and providers in health care treatment decisions.
    Hogue EE
    Pediatr Nurs; 1990; 16(3):317-8. PubMed ID: 2359664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare reimbursement for physician services: the current status of local payment policy.
    Allen B; Keysor KJ
    J Am Coll Radiol; 2005 Nov; 2(11):896-905. PubMed ID: 17411963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgonomics as a health care financing policy for hospitalized surgical patients.
    Muñoz E; Goldstein J; Benacquista T; Mulloy K; Wise L
    Surg Gynecol Obstet; 1989 May; 168(5):421-5. PubMed ID: 2496483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-party reimbursement for diabetes care, self-management education, and supplies.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S111-2. PubMed ID: 12017670
    [No Abstract]   [Full Text] [Related]  

  • 17. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Reimbursement of Genetic Counseling Services at a Single Institution in a State Requiring Licensure.
    Leonhard JR; Munson PJ; Flanagan JD; De Berg KL; Thompson PA; Dean LW; Stein QP
    J Genet Couns; 2017 Aug; 26(4):852-858. PubMed ID: 28181058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior.
    DeWitt EM; Glick HA; Albert DA; Joffe MM; Wolfe F
    Arch Intern Med; 2006 Jan; 166(1):57-63. PubMed ID: 16401811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the Medicare home health care market: the impact of reimbursement policy.
    Choi S; Davitt JK
    Med Care; 2009 Mar; 47(3):302-9. PubMed ID: 19194328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.